Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib By imwgimf On January 26, 2012 · Add Comment · In IMWG Publications, Relapse Read More »
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group By imwgimf On April 15, 2008 · Add Comment · In IMWG Publications, Transplant, Treatment Options Read More »